Home › Funds › Geode Capital Management › VRTX
Geode Capital Management position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)6.02M sh
Reported value held$2.98B
Portfolio Weight0.16%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 4.30M | $778.28M | New |
| Q4 2021 | 4.36M | $954.28M | Add |
| Q1 2022 | 4.33M | $1.13B | Reduce |
| Q2 2022 | 4.53M | $1.28B | Add |
| Q3 2022 | 5.27M | $1.52B | Add |
| Q4 2022 | 5.38M | $1.55M | Add |
| Q1 2023 | 5.41M | $1.70B | Hold |
| Q2 2023 | 5.54M | $1.95B | Add |
| Q3 2023 | 5.60M | $1.94B | Add |
| Q4 2023 | 5.67M | $2.30B | Add |
| Q1 2024 | 5.81M | $2.42B | Add |
| Q2 2024 | 6.33M | $2.96B | Add |
| Q3 2024 | 5.94M | $2.75B | Reduce |
| Q4 2024 | 5.65M | $2.27B | Reduce |
| Q1 2025 | 5.76M | $2.78B | Add |
| Q2 2025 | 5.93M | $2.63B | Add |
| Q3 2025 | 5.97M | $2.33B | Add |
| Q4 2025 | 5.98M | $2.70B | Hold |
| Q1 2026 | 6.14M | $2.73B | Add |
| Q2 2026 | 6.02M | $2.98B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026